Telehealth

Keywords:
#
AAD 2024
#
Tissue Classifier
#
Conferences
#
Skin Care
#
AAD 2023
#
BioJapan2022
#
JAK inhibitors
SCR used in clinical trials in mycosis fungoides patients with Bimiralisib
News
•
Feb 26, 2023

New Study Shows Meaningful Results with Bimiralisib in Mycosis Fungoides Patients using Scarletred®Vision

Topical Bimiralisib, used in patients with the rare cutaneous form of T-cell lymphoma, known as Mycosis fungoides, and healthy patients, showed substantial results regarding cutaneous drug levels.
SCARLETRED exhibted at the EXPO 2020 in the Austrian Pavilion from January until the end of March
News
•
Jan 21, 2022

Visit SCARLETRED at the EXPO 2020 - Connecting Minds, Creating the Future

The EXPO 2020 “Connecting Minds, Creating the Future” theme addresses visions of a networked and technology-based future. SCARLETRED is currently exhibited in the iLab section representing the future of digital healthcare.
Doctor is holding tablet in hands, using telemedine with ScalretredVision skin patch
News
•
Sep 27, 2021

The Evolution of SCARLETRED and Artificial Intelligence Assisted Screening in Teledermatology

The clinically validated and award-winning technology, Scarletred®Vision, is on market since 2015, enabling high quality remote skin imaging and objective analysis in over 3000 cutaneous disorders.
Andreas Grassauer(Marinomed) Harald Schnidar(SCR) Stefanie Werinos-Sydow(PHH Rechtsanwälte) Thomas Erkinger(EOSS Industries)
News
•
Sep 21, 2021

SCARLETRED at Round-Table Discussion of Börse Express about Life Science Industry in Austria

​​In the round table discussion of the leading financial domain Börse Express, Marinomed, Scarletred, PHH Rechtsanwälte, and EOSS Industries discussed the development and hurdles of Austrian life science start-ups.
No items found.
Paper
•
November 30, 2023

Automated Classification of Hidradenitis Suppurativa Disease Severity by Convolutional Neural Network Analyses Using Calibrated Clinical Images

Read more